Tuesday, August 26, 2025

Raffles Medical - 26 Aug 25

Raffles Medical (SGX: BSL) – Daily timeframe (Jan–Aug 2025, ~160 bars) with last traded price at 1.01 SGD.


1. Market Structure & Order Flow

  • Trend Structure:

    • Early 2025: sharp markup phase (0.80 → 1.03, Feb–Mar).

    • April retrace to 0.90 SL, followed by a new swing high at 1.05 (May)higher-high, higher-low progression intact.

    • June retest low 0.94, then rebound.

    • July–Aug: push to 1.09 (SH), followed by rejection and pullback into 0.99–1.01 zone.

    • Current regime = transition from trending up → rangebound distribution.

  • Break of Structure (BOS):

    • BOS down noted after 1.09 rejection, with SL formed at 0.99.

    • Current lower-highs forming (1.09 → 1.05 → 1.03), signaling momentum decay.

  • Order Flow Imbalances:

    • Institutional supply present around 1.05–1.09 zone (heavy rejection, wide-body down bars).

    • Demand test at 0.94–0.99, with buying tails suggesting accumulation interest.


2. Volume-Price Relationship (VPR)

  • Absorption Zones:

    • Mar rally → heavy volume, small retraces → institutional accumulation.

    • Aug 1.09 rejection → wide range, high volume → climactic supply bar.

  • Volume Divergence:

    • Successive highs (1.05 → 1.09) on declining volume → weakening buyer pressure.

    • Support re-tests near 0.94–0.99 with stabilizing volume → possible absorption.

  • Clusters:

    • Major volume at 0.94–0.99 demand zone, and 1.05–1.09 supply zone → key battlegrounds.


3. Institutional Footprints

  • Liquidity Grab:

    • Aug spike to 1.09 likely stop-run above prior SH (1.05), immediately rejected → classic upthrust (UTAD in Wyckoff terms).

  • Order Blocks:

    • Demand OB: 0.94–0.99 (tested multiple times, buyers defending).

    • Supply OB: 1.05–1.09 (institutional distribution zone).

  • Fair Value Gaps:

    • Thin liquidity between 0.96–0.99, repeatedly tested.


4. Bar Pattern Recognition

  • Reversal Bars:

    • Aug rejection bar off 1.09 = wide range engulfing, heavy volume → bearish control.

  • Continuation Bars:

    • Several inside bars post-selloff, indicating coiling near 1.00.

  • Indecision:

    • Current bar (1.01 close) = small body, low conviction → market waiting for breakout trigger.


5. Multi-Timeframe Confluence

  • Weekly chart bias (higher TF): still in broader uptrend from 0.80 base, but showing distribution near 1.05–1.10.

  • Daily compression: 1.00 midpoint acting as pivot → repeated rejections and supports.


6. Psychological Levels

  • 1.00 SGD = key psychological battleground (currently at it).

  • 0.90 = prior strong demand base.

  • 1.10 = round number resistance not yet cleared.


7. Market Regime Classification

  • Current regime: Range/Distribution between 0.94 (support) and 1.09 (resistance).

  • Transition signals: Lower highs, failed follow-through after 1.09 → sellers gaining control.


8. Key Observations (Highest Conviction)

  1. Institutional upthrust at 1.09 with rejection = supply confirmed.

  2. Demand defended at 0.94–0.99 zone, but repeated tests weaken support.

  3. Volume divergence on highs = buyer exhaustion.

  4. 1.00 psychological level = current battleground; break below likely accelerates selling.

  5. Range regime dominates; breakout confirmation required for directional bias.


9. Forward-Looking Bias

  • Bullish scenario: If 1.00 holds with absorption + breakout above 1.05, retest 1.09–1.10.

  • Bearish scenario: Failure to hold 0.99–1.00 → liquidity vacuum to 0.94, extended target 0.90.


Trade Summary

Selling Raffles Medical (SGX: BSL) because of institutional upthrust rejection at 1.09 and weakening demand at 1.00, with stops above 1.05 targeting 0.94 for ~1:2.5 risk-reward.
Confidence Rating: 7/10

Key Levels to Watch:

  • Support: 0.94 / 0.90

  • Resistance: 1.05 / 1.09

  • Pivot: 1.00

Execution Checklist Before Trade:
☑ Confirm volume on 1.00 breakdown
☑ Align with higher timeframe bias
☑ Define stop strictly above 1.05
☑ Monitor for false breakdown traps


Disclaimer:Please note that this analysis is for educational purposes only and should not be taken as investment advice. Trading involves significant risk, and you should consult with a financial advisor before making any decisions.

Dividend:   2.48%



No comments:

Post a Comment

Singapore Stock Investment Research